Paper10692996
The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.
Heym B and 2 others. Tuber Lung Dis, 1999. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. The molecular basis of isoniazid resistance in Mycobacterium tuberculosis. Papers, record 10692996. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10692996
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Bacterial Proteins | Major topic |
| Isoniazid | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Peroxidases | Major topic |
| Catalase | |
| Drug Resistance | |
| Humans | |
| Peroxidase | |
| Tuberculosis |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36718771 | Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line. | Genet Mol Biol | 2023 | https://conductscience.org/library/papers/36718771 | PubMed |
| 30140323 | Molecular Analysis of katG Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis. | J Med Life | 2018 | https://conductscience.org/library/papers/30140323 | PubMed |
| 29550921 | Genotyping of Mycobacterium tuberculosis using whole genome sequencing. | Folia Microbiol (Praha) | 2018 | https://conductscience.org/library/papers/29550921 | PubMed |
| 29085406 | Anti-mycobacterium tuberculosis activity of polyherbal medicines used for the treatment of tuberculosis in Eastern Cape, South Africa. | Afr Health Sci | 2017 | https://conductscience.org/library/papers/29085406 | PubMed |
| 24083144 | First experience with using simple polymerase chain reaction-based methods as an alternative to phenotypic drug susceptibility testing for Myobacterium tuberculosis in Iraq. | Int J Appl Basic Med Res | 2013 | https://conductscience.org/library/papers/24083144 | PubMed |
| 23287547 | Challenges in the development of drugs for the treatment of tuberculosis. | Braz J Infect Dis | 2013 | https://conductscience.org/library/papers/23287547 | PubMed |
| 19451293 | A balancing act: efflux/influx in mycobacterial drug resistance. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19451293 | PubMed |
| 16390970 | Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance. | J Clin Microbiol | 2006 | https://conductscience.org/library/papers/16390970 | PubMed |
| 15328099 | Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15328099 | PubMed |
| 12381217 | Therapeutic drug monitoring in the treatment of tuberculosis. | Drugs | 2002 | https://conductscience.org/library/papers/12381217 | PubMed |
| 11796329 | Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/11796329 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10692996
GET https://conductscience.org/api/papers/v1/10692996/authors